General medical practice activities
ENDOKRINOLOGI OG INDREMEDISIN AS
Revenue 2024
NOK 1.7m
Operating profit
NOK −727,000
Equity
NOK −721,000
Incorporated
2024
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.42
Equity ratio
-18.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -43.3% | |
| Net margin (%%) | -44.4% | |
| Return on assets (%%) | -18.7% | |
| Likviditet | ||
| Current ratio | 0.42 | |
| Working capital | −722k | |
| Soliditet | ||
| Equity ratio (%%) | -18.5% | |
| Debt-to-equity ratio | -6.40 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.